Alteration of proteolytic processing of c-Myb as a consequence of its truncation in murine myeloid leukemia.
Bies
J
J
Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, MD, USA.
Nazarov
V
V
Wolff
L
L
D000818:Animals; D002453:Cell Cycle; D002454:Cell Differentiation; D010450:Endopeptidases / Q000378:metabolism*; D005091:Exons / Q000235:genetics; D015850:Interleukin-6 / Q000494:pharmacology; D016350:Leucine Zippers; D007951:Leukemia, Myeloid / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D016254:Mutagenesis, Insertional; D009363:Neoplasm Proteins / Q000737:chemistry / Q000378:metabolism*; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000378:metabolism; D010443:Peptide Chain Termination, Translational; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational; D011518:Proto-Oncogene Proteins / Q000737:chemistry / Q000378:metabolism*; D020598:Proto-Oncogene Proteins c-myb; D015534:Trans-Activators / Q000737:chemistry / Q000378:metabolism*
D015850:Interleukin-6; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; D020598:Proto-Oncogene Proteins c-myb; D015534:Trans-Activators; D010450:Endopeptidases